Article

Cell-Free DNA Analysis for Noninvasive Examination of Trisomy

2015-08-01

Abstract excerpt

Obstet Gynecol Surv 2015;70(8):483–484 While cell-free DNA (cfDNA) testing for fetal aneuploidy has been shown to have a high detection rate for trisomy, most large studies have included only high-risk populations. This blinded, prospective study tested the performance of screening with cfDNA for common trisomies in the general population.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c8b28818-4a95-5fdc-9c63-306841786e64
DOI: 10.1097/01.ogx.0000470657.58577.f2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cell-Free DNA Analysis for Noninvasive Examination of TrisomyDOI 10.1097/01.ogx.0000470657.58577.f2Read

Cell-free DNA Analysis for Noninvasive Examination of TrisomySemantic proximity Read

Cell-free DNA Analysis for Noninvasive Examination of TrisomySemantic proximity Read

Analysis of Cell-Free DNA in Maternal Blood in Screening for Aneuploidies: Meta-AnalysisSemantic proximity Read

Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variantsSemantic proximity Read

Analysis of cell‐free DNA in maternal blood in screening for aneuploidies: updated meta‐analysisSemantic proximity Read

Analysis of cell‐free <scp>DNA</scp> in maternal blood in screening for fetal aneuploidies: updated meta‐analysisSemantic proximity Read

Current controversies in prenatal diagnosis 2: Cell‐free DNA prenatal screening should be used to identify all chromosome abnormalitiesSemantic proximity Read

Multisite assessment of the impact of cell-free DNA-based screening for rare autosomal aneuploidies on pregnancy management and outcomesSemantic proximity Read

Cell‐free <scp>DNA</scp> testing of maternal blood in screening for trisomies in twin pregnancy: updated cohort study at 10–14 weeks and meta‐analysisSemantic proximity Read

Clinical performance of non‐invasive prenatal testing (NIPT) using targeted cell‐free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studiesSemantic proximity Read

Noninvasive screening by cell‐free DNA for 22q11.2 deletion: Benefits, limitations, and challengesSemantic proximity Read

Cell-free DNA testing of an extended range of chromosomal anomalies: clinical experience with 6,388 consecutive casesSemantic proximity Read